Melanoma Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q3 | 39.4% | 0.740 | Q2 | 74.7% |
| 2024 | 1.9 | Q3 | 45.8% | 0.657 | Q2 | 71.5% |
| 2023 | 1.5 | Q4 | 19.8% | 0.633 | Q2 | 72.6% |
| 2022 | 2.2 | Q3 | 28.3% | 0.740 | Q1 | 78.4% |
| 2021 | 3.2 | Q3 | 45.0% | 0.829 | Q1 | 82.1% |
| 2020 | — | — | 1.072 | Q1 | 86.8% | |
| 2019 | — | — | 0.854 | Q1 | 82.0% | |
| 2018 | — | — | 1.086 | Q1 | 86.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0960-8931
ISSN
1473-5636
country
UScoverage
1991-2026